| CSK |
CSK: Tyrosine-protein kinase CSK |
SHC1 |
SHC1, RP11-307C12.1-001, hCG_1997126: SHC |
2.102 |
Evidence |
|
| APC |
IPI00215877 |
GSK3B |
IPI00216190 |
2.102 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
EP300 |
IPI00478752 |
2.102 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
2.1 |
Evidence |
|
| ARPC3 |
ARPC3, ARC21: Actin-related protein 2/3 complex subunit 3 |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
2.077 |
Evidence |
O
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
2.065 |
Evidence |
O
|
| KPNA6 |
IPI00155940 |
RFC4 |
RFC4: Replication factor C subunit 4 |
2.06 |
Evidence |
O
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
WIRE |
WIPF2, WICH, PP10631, WIRE: WAS/WASL-interacting protein family member 2 |
2.045 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
CDT1 |
CDT1: DNA replication factor Cdt1 |
2.042 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
2.042 |
Evidence |
O
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
2.04 |
Evidence |
O
|
| CCR5 |
CCR5: CCR5 receptor (Fragment) |
GNAI2 |
Galphai2 protein |
2.015 |
Evidence |
|
| ZFHX1B |
Zinc finger homeobox protein 1b |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
2.007 |
Evidence |
O
|
| IFNAR2 |
IPI00220690 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
2.007 |
Evidence |
|
| NFE2L2 |
NFE2L2, NRF2: Nuclear factor erythroid 2-related factor 2 |
NFE2 |
NFE2: Transcription factor NF-E2 45 kDa subunit |
2.005 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
2.005 |
Evidence |
O
|
| SUV39H1 |
SUV39H1, SUV39H: Histone-lysine N-methyltransferase SUV39H1 |
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
2.005 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CSF3R |
IPI00216365 |
1.987 |
Evidence |
|
| FADD |
FADD, MORT1: Protein FADD |
CASP8 |
IPI00305242 |
1.982 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
1.98 |
Evidence |
|
| PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
1.977 |
Evidence |
O
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
1.967 |
Evidence |
|
| KRT18 |
KRT18: Uncharacterized protein KRT18 |
KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
1.965 |
Evidence |
O
|
| ARCN1 |
ARCN1, COPD: Coatomer subunit delta |
COPB |
IPI00556322 |
1.957 |
Evidence |
|
| TXNL2 |
GLRX3, PICOT, HUSSY-22, TXNL2: Glutaredoxin-3 |
TP53RK |
TP53RK, C20orf64, PRPK: TP53-regulating kinase |
1.945 |
Evidence |
O
|
-